Bacteriology



Bacteriology


Regis P. Kowalski

Jules L. Baum



Bacteria are single-celled prokaryotes and one of the earliest life forms. Although bacteria naturally inhabit many exterior and interior areas of the human body, the normal human cornea harbors no colonizing bacteria, but bacteria from the eyelids constantly contaminate the ocular surface. Host defense mechanisms of the eye and adnexa provide excellent corneal protection for the elimination of microbes through (a) mechanical, (b) immunologic, (c) chemical, and (d) innate mechanisms (1).

Bacteria colonize the cornea in infection, or some other pathologic process that compromises basic defense mechanisms, thus allowing growth. Bacteria that cause disease are labeled as pathogens because they possess virulence factors that enable the survival of these organisms in the cornea. These virulence factors include specific antigens, proteolytic enzymes, hemolysins, and toxins (2). In general, nonpathogens do not possess significant virulence factors, but under compromised conditions, may gain access to the cornea. Bacteria become established in the cornea after a breakdown of the corneal epithelium due to mechanical or nutritional stress, and proliferate under continued favorable conditions for bacterial growth (3).

The cornea may become infected from a pathogen in a wide range of bacteria, classified in part by the staining characteristics of the cell wall. The classic differential staining system is based on the Gram stain, which separates bacteria into gram-positive and gram-negative bacteria (Fig. 12-1). The staining procedure starts with placement of a corneal tissue specimen or a suspension of bacteria isolated from culture media on a glass microscope slide. The specimen is air-dried and fixed with methanol or a comparable fixative. In consecutive steps, it is stained with crystal violet, rinsed with tap water, stained with iodine, decolorized with alcohol (alcohol/acetone mixture), and counterstained with safranin. Gram-positive bacteria have a high content of peptidoglycan and a low content of lipid compared with gram-negative bacteria. When the lipid layer is dissolved, crystal violet and iodine form a complex in the cell wall that appears blue under microscopic examination, denoting gram-positive bacteria. Gram-negative bacteria appear red because the lipid layer is not removed by the decolorizing step. A blue crystal violet complex can not form in the cell wall and safranin counterstains the bacteria. Other stains, such as an acid-fast stain, are also used to differentiate Mycobacterium species from other bacteria (4). Gram-positive bacteria are more frequently isolated from patients with keratitis than are gram-negative bacteria. In our laboratory (The Charles T. Campbell Ophthalmic Microbiology Laboratory, Pittsburgh, PA, 1993 to 2002), 56% of the bacterial keratitis isolates were gram-positive and 44% were gram-negative (Fig. 12-2). This ratio is consistent with other reports from China (60.2% vs. 39.6%) (5), England (54.7% vs. 45.3%) (6), and Boston (60% vs. 40%) (7).


BACTERIAL IDENTIFICATION METHODS

The vast majority of bacteria are easily cultivated in the basic microbiology laboratory using culture media. A broth-based agar medium supplemented with 5% to 10% sheep blood (blood agar), a chocolate agar (red cells partially lysed by heat) plate, and an optional mannitol salt agar plate will isolate almost all corneal bacterial pathogens. Anaerobic media such as enriched thioglycollate broth medium and broth-based agar media incubated under anaerobic conditions suffice for anaerobic bacterial isolation. Most bacteria appear on culture media with distinct characteristics that allow for immediate identification. Colony shape, size, color, and edge appearance, medium color changes due to production of end products (e.g., mannitol salt agar), and hemolysis of blood in supplemented media (i.e., beta-, alpha-Streptococci) due to production of lysins are examples of identification characteristics. As a rule, most bacteria can be identified to a bacterial genus or as gram-positive or gram-negative by appearance, but further identification to species requires the use of biochemicals (e.g., indole, glucose fermentation), antisera (e.g., coagulase), and changing growth conditions (e.g., Haemophilus growth factors). Bacteria are also characterized by specific oxygen requirements. Strict aerobic
bacteria (aerobes) require oxygen for growth, whereas oxygen is toxic to other bacteria. These bacteria are classified as anaerobes. Many bacteria are facultative anaerobes in that growth occurs under either aerobic or anaerobic conditions. Bacteria also grow better at certain temperature and atmospheric conditions. In general, bacteria are incubated for isolation at body temperature (37°C or 98.6°F) and under a 6% CO2 atmospheric condition. Mycobacteria require different incubating temperatures, different light conditions, and extended incubation periods for isolation and identification.






FIGURE 12-1. Microphotographs of gram-positive (blue) and gram-negative (red) bacteria that infect the cornea. (Original magnification × 100, oil immersion; photographed by Lisa M. Karenchak.) Row 1, left: diplococci (Streptococcus pneumoniae); row 1, middle: pleomorphic rods (diphtheroids); row 1, right: diplobacilli (Moraxella). Row 2, left: chain of cocci (Streptococcus); row 2, middle: rods with endospores (Bacillus); row 2, right: rods (Pseudomonas aeruginosa). Row 3, left: grapelike clusters of cocci (Staphylococcus aureus); row 3, middle: thin filaments (Actinomyces); row 3, right: nonstaining ghost rods (Mycobacterium chelonae). (See color figure.)






FIGURE 12-2. Distribution of bacteria isolated from cases of keratitis (1993 to 2002). Gram-positive bacteria comprised 56% of isolates, and gram-negative bacteria 44%. (Courtesy of the Charles T. Campbell Ophthalmic Microbiology Laboratory, The University of Pittsburgh Medical Center, Pittsburgh, PA.)

Antibiotic susceptibility patterns are often used to identify and characterize bacteria. Susceptibility to vancomycin usually denotes a gram-positive bacteria, whereas bacitracin resistance is a characteristic of Haemophilus species. Staphylococcus aureus that are resistant to oxacillin are designated as methicillin resistant. Tables 12-1 and 12-2 include the susceptibility patterns of bacterial keratitis pathogens isolated from the Charles T. Campbell Ophthalmic Microbiology Laboratory 1993 to 2002. Although this chapter does not deal with keratitis therapy, susceptibility patterns are important in epidemiology and strain characterization. Minimum inhibitory concentrations or disk diffusion patterns using standard methods are determined and compared with established standards that interpret susceptibility (8,9). In the United States, bacterial susceptibility is determined using the serum standards established by the National Committee of Clinical Laboratory Standards (NCCLS). Most general laboratories do not test all the antibiotics presented in Tables 12-1 and 12-2 because some of these antibiotics are not used for treatment of systemic disease. There are no standards for interpretation
of antibacterial susceptibility for bacterial keratitis isolates because therapy is topical instead of systemic. NCCLS susceptibility interpretations can be used for ocular isolates if the assumption is made that the antibiotic concentration in the ocular tissue is at least as great as the antibiotic concentrations achieved in the blood serum.








TABLE 12-1. SUSCEPTIBILITY OF GRAM-POSITIVE BACTERIAL ISOLATES FROM KERATITIS TO COMMON ANTIBIOTICS (PERCENTAGE SUSCEPTIBLE, 1993-2002)



































































































































































Bacteria


No.


BAC


CHL


VAN


GEN


CIP


OFX


TRI


PB


CEF


TOB


SULF


OXA


Staphylococcus aureus


264


97


98


100


89


71


74


89


1


92


72


95


63


Coagulase-negative staphylococci


95


94


90


100


66


45


45


55


25


88


64


78


26


Streptococcus pneumoniae


52


100


94


100


4


54


79


22


2


100


0


94


Streptococcus viridans


73


100


97


100


42


33


75


43


4


99


22


100


Beta-hemolytic streptococci


8


100


100


100


25


63


88


25


0


100


0


38


Nutritionally variant streptococci


6


50


100


100


17


33


100


25


0


83


0


17


Enterococcus species


10


80


40


90


10


40


50


60


0


20


10


30


Nonhemolytic streptococci


2


100


100


100


0


0


0


0


0


50


0


0


Diphtheroids


32


91


84


100


81


58


65


6


91


91


78


75


Bacillus species


5


40


80


100


100


100


100


100


60


80


100


100



BAC, bacitracin; CHL, chloramphenicol; VAN, vancomycin; GEN, gentamicin; CIP, ciprofloxacin; OFX, ofloxacin; TRI, trimethoprim; PB, polymyxin B; CEF, cefazolin; TOB, tobramycin; SULF; sulfasoxazole; OXA, oxacillin.
(Data courtesy of the Charles T. Campbell Ophthalmic Microbiology Laboratory, The University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.)









TABLE 12-2. SUSCEPTIBILITY OF GRAM-NEGATIVE BACTERIAL ISOLATES FROM KERATITIS TO COMMON ANTIBIOTICS (PERCENTAGE SUSCEPTIBLE; 1993-2002)



























































































































































































































































































































































































































Bacteria


No.


BAC


CHL


VAN


GEN


CIP


OFX


TRI


PB


CEF


TOB


SULF


Pseudomonas aeruginosa


122


0


0


0


96


97


92


0


100


0


98


2


Serratia marcescens


122


0


89


0


99


100


100


84


3


0


88


84


Serratia liquefaciens


4


0


100


0


100


100


100


100


100


0


100


100


Serratia species


7


0


100


0


100


100


100


83


43


0


100


67


Moraxella species


40


100


100


98


100


100


100


5


100


98


100


100


Haemophilus species


26


4


100


4


77


100


100


85


96


56


81


65


Acinetobacter species


20


10


25


15


100


95


95


0


95


10


95


100


Enterobacter species


18


0


94


6


100


100


100


86


100


50


100


100


Hafnia alvei


1


0


100


0


100


100


100



0


0


100


100


Klebsiella species


5


0


80


0


100


100


100


50


100


100


100


80


Escherichia coli


10


10


90


0


100


100


100


100


100


90


100


90


Citrobacter species


2


0


100


0


100


100


100


100


100


50


100


100


Shigella sonnei


1


0


100


0


100


100


100


100


100


100


100


100


Proteus mirabilis


14


0


92


0


100


100


100


57


0


86


100


100


Proteus vulgaris


2


0


50


0


100


100


100



0


50


100


100


Morganella morganii


4


0


100


0


100


100


100


50


0


0


100


100


Providencia stuartii


1


0


0


0


0


0


0


0


0


0


0



Branhamella catarrhalis


8


100


100


13


100


100


88


0


100


75


100


88


Neisseria subflava


1


100


100


100


100


100


100



100


100


100


100


Pasteurella haemolytica


1


0


0


100


100


100


100



100


100


100


100


Capnocytophaga species


1


100


100


50


100


100


100


100


100


50


100


100


Alcaligenes species


7


0


43


0


29


71


86


0


100


0


29


100


Flavobacterium species


3


66


66


100


33


100


100



33


33


0


100


Stenotrophomonas maltophilia


4


0


67


25


25


75


75


0


75


0


25


100


Burkholderia cepacia


1


0


0


0


0


100


100


0


100


0


0


100


Brevundimonas vesicularis


1


0



100


0


0


100



100


0


0


100


Pseudomonas stutzeri


1


0



0


100


100


100



100


0


100


0


Pseudomonas species


1


0


0


0


100


0


0


0


0


0


100


100


BAC, bacitracin; CHL, chloramphenicol; VAN, vancomycin; GEN, gentamicin; CIP, ciprofloxacin; OFX, ofloxacin; TRI, trimethoprim; PB, polymyxin B; CEF, cefazolin; TOB, tobramycin; SULF, sulfasoxazole.
(Data courtesy of the Charles T. Campbell Ophthalmic Microbiology Laboratory, The University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 18, 2016 | Posted by in OPHTHALMOLOGY | Comments Off on Bacteriology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access